Latest period
$412.20M
YoY change
+23.7%
5Y CAGR
—
Peak year (2025)
$377.70M
Latest annual
$377.70M
Free Cash Flow history chart for Insulet (PODD) from 2004 to 2025
Latest: $377.70M
Free Cash Flow growth chart for Insulet (PODD) from 2004 to 2025
Latest: +23.7%
Free Cash Flow history table for Insulet (PODD) from 2004 to 2025
| 2025 | $377.70M | +23.7% | +$72.30M | ||
| 2024 | $305.40M | +335.7% | +$235.30M | ||
| 2023 | $70.10M | -283.0% | +$108.40M | ||
| 2022 | −$38.30M | -79.9% | +$152.50M | ||
| 2021 | −$190.80M | +131.3% | −$108.30M | ||
| 2020 | −$82.50M | +13.8% | −$10.00M | ||
| 2019 | −$72.50M | -42.7% | +$53.95M | ||
| 2018 | −$126.45M | +251.1% | −$90.44M | ||
| 2017 | −$36.02M | +480.6% | −$29.82M | ||
| 2016 | −$6.20M | -73.2% | +$16.96M | ||
| 2015 | −$23.16M | +802.6% | −$20.59M | ||
| 2014 | −$2.57M | -35.2% | +$1.39M | ||
| 2013 | −$3.96M | -90.1% | +$36.09M | ||
| 2012 | −$40.05M | +9.5% | −$3.48M | ||
| 2011 | −$36.57M | -13.3% | +$5.61M | ||
| 2010 | −$42.17M | -19.6% | +$10.29M | ||
| 2009 | −$52.46M | -43.4% | +$40.20M | ||
| 2008 | −$92.66M | +53.3% | −$32.20M | ||
| 2007 | −$60.46M | +34.5% | −$15.50M | ||
| 2006 | −$44.96M | +74.3% | −$19.16M | ||
| 2005 | −$25.79M | +63.6% | −$10.03M | ||
| 2004 | −$15.76M | — | — |
- 2025$377.70M+23.7%
- 2024$305.40M+335.7%
- 2023$70.10M-283.0%
- 2022−$38.30M-79.9%
- 2021−$190.80M+131.3%
- 2020−$82.50M+13.8%
- 2019−$72.50M-42.7%
- 2018−$126.45M+251.1%
- 2017−$36.02M+480.6%
- 2016−$6.20M-73.2%
- 2015−$23.16M+802.6%
- 2014−$2.57M-35.2%
- 2013−$3.96M-90.1%
- 2012−$40.05M+9.5%
- 2011−$36.57M-13.3%
- 2010−$42.17M-19.6%
- 2009−$52.46M-43.4%
- 2008−$92.66M+53.3%
- 2007−$60.46M+34.5%
- 2006−$44.96M+74.3%
- 2005−$25.79M+63.6%
- 2004−$15.76M—
Free Cash Flow values are taken from Insulet's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Insulet (PODD)
Free Cash Flow for Insulet (PODD): headline value $412.20M · YoY +23.7%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual free cash flow for Insulet (PODD) came in at $377.70M – grew 23.7% year-over-year.
The record annual free cash flow stands at $377.70M, reached in 2025; the historical low of −$190.80M was recorded in 2021.
Insulet Free Cash Flow by Year
Insulet Free Cash Flow 2025: $377.70M
Insulet free cash flow in 2025 was $377.70M, grew 23.7% from 2024. This figure represents the highest annual value in the available history.
Insulet Free Cash Flow 2024: $305.40M
2024's free cash flow for Insulet came in at $305.40M, surged 335.7% from 2023.
Insulet Free Cash Flow 2023: $70.10M
Insulet posted free cash flow of $70.10M in 2023, plunged 283.0% below 2022.
Insulet Free Cash Flow 2022: −$38.30M
In 2022, Insulet reported free cash flow of −$38.30M, plunged 79.9% below 2021.
Insulet Free Cash Flow 2021: −$190.80M
Insulet free cash flow in 2021 was −$190.80M.
See more financial history for Insulet (PODD).
Sector peers by Free Cash Flow
Healthcare peers of Insulet (PODD), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.97B | |
| $8.67B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.97B
- $8.67B
- $8.10B
- $4.52B
Frequently asked questions
Insulet (PODD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation